Revised SPCs: Rapifen and Rapifen IC (alfentanil)

Information on drug dependence, tolerance and potential for abuse, drug withdrawal syndrome, hyperalgesia, the risk from concomitant use of CNS depressants, and on use during pregnancy and breastfeeding has been added to the SPC.

Source:

electronic Medicines compendium